Hypolipidemic activity of Coriandrum sativum in diabetic dyslipidemic rats

Sayan Das; Vikram Rajadnya; Revati Kothari; A. V. Tilak; Siddhi Raveendran; Teja Deshpande

doi:10.18203/2319-2003.ijbcp20192208

Authors

Sayan Das Department of Pharmacology, Dr. DY Patil Medical College and Hospital, Pune, Maharashtra, India
Vikram Rajadnya Department of Pharmacology, Dr. DY Patil Medical College and Hospital, Pune, Maharashtra, India
Revati Kothari Department of Pharmacology, Dr. DY Patil Medical College and Hospital, Pune, Maharashtra, India
A. V. Tilak Department of Pharmacology, Dr. DY Patil Medical College and Hospital, Pune, Maharashtra, India
Siddhi Raveendran Department of Pharmacology, Dr. DY Patil Medical College and Hospital, Pune, Maharashtra, India
Teja Deshpande Department of Pharmacology, Dr. DY Patil Medical College and Hospital, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20192208

Keywords:

Atherogenic index, Cardiovascular risk, Coriandrum sativum, Dyslipidemia, HDL, Metabolic syndrome, Metformin

Abstract

Background: Metabolic syndrome is described as the clustering of obesity, aberrant glucose metabolism, dyslipidemia and hypertension. A characteristic pattern, termed diabetic dyslipidemia, consists of low HDL, increased triglycerides and postprandial lipemia. This pattern is most frequently seen in type 2 diabetes and may be a treatable risk factor for subsequent cardiovascular disease. This study was designed to compare the hypolipidemic activity of Coriandrum sativum L. with the standard antidiabetic drug, metformin in streptozotocin induced diabetic rats.

Methods: Streptozotocin (STZ) was used to induce diabetes in the rats. The hypolipidemic activity of Coriandrum sativum seed extract was compared to the standard drug metformin. 4 groups (n=8) (normal control, diabetic control, streptozotocin+Coriandrum sativum and streptozotocin+metformin). The drugs were administered once daily for 28 days following which lipid profile was estimated on 28^th day by using blood sample collected from the retro-orbital space.

Results: STZ induced diabetes and also lead to dyslipidemia. Oral administration of CS seed extracts significantly lowered total cholesterol (TC), LDL:HDL ratio, TC:HDL ratio, thus, reducing the cardiovascular risk. HDL levels were slightly increased with CS seed extract compared to diabetic control group but not statistically significant. There was also statistically insignificant reduction in the atherogenic index with CS seed extract compared to diabetic control.

Conclusions: CS seed extract (40 mg/kg) orally may have considerable therapeutic benefit as a hypolipidemic agent and can be suggested as a potential dietary add on.

Metrics

Metrics Loading ...

References

Petrucelli OM. The metabolic syndrome. Northeast Florida Med. 2008;59(3):18-21.

Malik S, Wong ND, Franklin SS, Kamat TV, L Ítalien GJ, Pio JR, et al. Impact of the metabolic syndrome on the mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-50.

Sahib NG, Anwar F, Gilani AH, Hamid AA, Saari N, Alkharfy KM. Coriander (Coriandrum sativum L.): a potential source of high-value components for functional foods and neutraceuticals: a review. Phytother Res. 2013;27:1439-56.

Aissaoui A, Zizi S, Israili ZH, Lyoussi B. Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats. J Ethnopharmacol. 2011;137(1):652-61.

Sreelatha S, Inbavalli R. Antioxidant, antihyperglycemic, and antihyperlipidemic effects of Coriandrum sativum leaf and stem in alloxan-induced diabetic rats. J Food Sci. 2012;77:119-23.

Pirkola J, Tammelin T, Bloigu A, Pouta A, Laitinen J, Ruokonen A, et al. Prevalence of metabolic syndrome at age 16 using international diabetes federation pediatric definition. Arch Dis Child. 2008;93:945-5.

Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi S, Farhangi A, Verdi AA, et al. Induction of diabetes by Streptozotocin in Rats. Indian J Clin Biochem. 2007;22(2):60-4.

Malik S, Wong ND, Franklin SS, Kamat TV, L Ítalien GJ, Pio JR, et al. Impact of the metabolic syndrome on the mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-50.

Grundy SM, Brewer HB, CLeeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-8.

Naquvi KJ, Ali M, Ahamad J. Antidiabetic activity of aqueous extract of coriandrum sativum fruits in streptozotocin induced rats. Int J Pharm Pharmaceut Sci. 2012;4(1):239-41.

Das S, Chaware S, Narkar N, Tilak AV, Raveendran S, Rane P. Antidiabetic activity of Coriandrum sativum in Streptozotocin induced diabetic rats. Int J Basic Clin Pharmacol. 2019;8(5):925-9.

Rajeshwari U, Iyer S, Bondada A. Comparison of aniseeds and coriander seeds for antidiabetic, hypolipidemic and antioxidant activities. Spatula DD. 2011;1(1):9-16.

Dhanapakiam P, Joseph JM, Ramaswamy VK, Moorthi M, Kumar AS. The cholesterol lowering property of coriander seeds (Coriandrum sativum): mechanism of action. J Environ Biol. 2008;29(1):53-6.